RVC researchers say that the VetCompass study is the largest ever carried out into dental disease in cats using veterinary clinical records.
The study investigated a sample of 18,249 cats randomly selected from a study population of 1,255,130 cats in the UK in 2019.
Periodontal disease was recorded in 15.2% of the sample making it the most common disorder.
The cat breeds with the highest annual levels of this diagnosis were Siamese (18.7%), Maine Coon (16.7%) and British Short Hair (15.5%) as well as crossbreeds (15.4%).
The average bodyweight of cats with periodontal disease (5.7kg) was higher than for cats without periodontal disease (5.5kg).
The risk of periodontal disease rose steeply as cats got older, with cats aged 9 to 12 years being 6.7 times more likely to have periodontal disease compared with cats aged under 3 years.
Cats with periodontal disease were much more likely to have a range of other health conditions compared to cats without periodontal disease (x 1.8 risk).
These conditions included cardiac dysrhythmia (x 2.3 risk), ear discharge (x 2.3 risk) and hairball/furball (x 2.3 risk).
The researchers say that these findings suggest that periodontal disease should be acknowledged as a leading health and welfare issue in cats, and highlight the need for greater dental care in cats as they age.
The study was supported by an award from the Kennel Club Charitable Trust and Agria Pet Insurance.
They say that dogs which lose sensation following damage to the spinal cord from a slipped disc have a prognosis for recovery of about 50%.
However, there is no reliable way of determining which dog will recover and failing that, owners must wait weeks to months to see if there are any signs of recovery, during which time dogs may need anaesthesia, surgery, and intensive nursing care.
The researchers say that the stiffness of an organ can be a marker of how damaged it is.
So, for the research, a new ultrasound machine equipped with an advanced piece of software (known as ‘shear wave elastography’) – will be used to measure the stiffness of a dog’s spinal cord during surgery.
The dog’s recovery to walking after surgery will then be monitored routinely.
The results will allow researchers to see if a relationship between spinal cord stiffness at time of surgery and recovery exists.
If successful, this would help them provide a more accurate prognosis for dogs with spinal cord injury in the future.
If you have a case suitable for this study, CVS says they will receive a gold standard treatment for spinal cord injury, which will include spinal surgery.
They will also have an ultrasound of the spinal cord performed during surgery, a procedure taking approximately 15 minutes.
Contact referrals@highcroftvet.co.uk or nicolas.granger@bristolvetspecialists.co.uk.
BVS Neurology study from CVS (UK) Ltd on Vimeo.
Vetoquinol has announced the launch of Equistro Flexadin UCII, an equine joint supplement.
Equistro Flexadin UCII contains a new ingredient, UC-II, which the company claims is one of the most effective and influential ingredients available that aids and supports healthy joint function.
To celebrate the launch of Flexadin UCII Vetoquinol is offering a £10 money off voucher available through purchases of Horse & Hound magazine starting from November 10th.
Caitríona Mullin, Equine Product Manager at Vetoquinol UK Ltd said: "We are very excited about the launch of Flexadin UCII in the UK and Ireland, we have already received excellent feedback from our German and French colleagues. Flexadin UCII is a product that will further enhance our premium range of equine supplements formulated specifically for the performance horse."
In the Voice of the Profession survey, 52% of nearly 700 veterinary surgeons said it was their biggest concern, more than double the number that said so two years ago. The figure was even higher amongst veterinary surgeons working in companion animal practice, with 66% citing it as a major issue.
The BVA is highlighting these statistics and encouraging veterinary teams to talk to clients about responsible dog breeding and buying during this year's Puppy Awareness Week, which runs till 10th September.
The BVA and the Kennel Club run Canine Health Schemes which screen dogs for inherited conditions including hip and elbow dysplasia, hereditary eye disease, and Chiari-malformation/Syringomyelia. Dog owners and breeders can use the results to make more informed breeding decisions and help improve the health of breeds susceptible to debilitating or life-limiting inherited conditions.
Pre-breeding testing and screening are not just for purebred pedigree dogs - screening is also important for crossbreed dogs, such as Labradoodles and Cockerpoos, which are becoming increasingly popular.
BVA President Gudrun Ravetz said: "With breeding and hereditary defects emerging as the number one animal health and welfare concern for vets, it is more important than ever to screen before breeding dogs. Vets in practice regularly see cases of inherited conditions such as hip dysplasia and eye problems that are debilitating and distressing for dogs.
"The good news is that we have schemes and tests in place that help breeders and owners make sound judgements about responsible breeding. The BVA/KC Canine Health Schemes and Kennel Club DNA testing services are critical tools for breeders. Anyone thinking of breeding from their dog or thinking about buying a puppy should ask their vet about available health schemes and how they can be used to inform their decisions."
During Puppy Awareness Week, BVA is also working with the Animal Welfare Foundation to promote the use of the Puppy Contract, which contains a section for the breeder to fill out about any health screening or DNA results to offer reassurance to owners.
BVA, in partnership with ITN Productions, has developed a 4-minute film on responsible dog breeding and buying that can be played in practice waiting rooms or on social media channels, which also explains the process and benefits of the Canine Health Schemes.
More details about the BVA/KC Canine Health Schemes can be found at: https://www.bva.co.uk/Canine-Health-Schemes/
Photo: By DodosD - Own work, CC BY-SA 3.0, Link
White Cross Vets, a family run group, has been named by The Sunday Times as one of the best places to work in the UK, for the fifth year on the trot.
The company, which operates 16 practices, achieved the highest placing of any veterinary business, reaching 38 in The Sunday Times 'Best 100 Best Small Companies To Work For' league table. It is the first animal health / veterinary business to rank in the prestigious list 5 years running, and it remains the only veterinary practice ever to achieve a three star 'extraordinary' rating in the list’s history.
The Best Companies to Work For survey is now in its 17th year and is designed to rank the cream of Britain’s motivated workforces. It is widely recognised as the most searching and extensive research into employee engagement carried out in the UK.
To achieve the listing in the Best Companies table, all of the White Cross team anonymously answered a series of in-depth questions about everything from personal development opportunities, to workplace wellbeing, contributions in the local community and overall opinions about the business.
Tim Harrison, Managing Director of White Cross Vets, said: "It really has been a case of high fives all round since we found out about this year’s placing, which puts us in this prestigious league table for the fifth consecutive year. We are a family run business that places a huge amount of importance on the wellbeing and happiness of our people and to be recognised for that is incredibly rewarding."
White Cross Vets was also recently awarded with an industry award in recognition of the initiatives it has introduced to ensure its team remain happy, healthy and fulfilled in their work. The company scooped the Society of Practising Veterinary Surgeons’ inaugural Wellbeing Award after the judges scored entrants on everything from development opportunities through to stress reduction initiatives and how they promote wellbeing.
Tim added: "Our employment initiatives include everything from giving everybody a day off and cake for their birthday, right through to providing four donation days a year where people can volunteer with a charity of their choice. We also provide a health care scheme and recently started offering subsidised Fitbits and gym membership as well as running a cycle to work scheme.
"One of our big priorities also involves supporting mental health, and we provide training on this, alongside a 24 hour helpline for emotional and wellbeing support.
"In addition to all of this, each year we run an annual congress packed with Continuing Professional Development (CPD) opportunities and thought-leadership talks on the latest topics affecting our industry. It’s at this event that we also hold an awards ceremony for our 170 strong team, where vets, nurses and client care co-ordinators are singled out for their superb achievements."
SRUC, which is the biggest provider of veterinary nursing, livestock husbandry and animal care training in Scotland, says it will offer a core veterinary programme to address existing shortages in veterinary provision, in areas such as rural veterinary practice, food production, food safety and animal and public health.
The College is first establishing a working group to progress the plans for the school. The group will be chaired by Professor Sir Pete Downes, former Principal and Vice-Chancellor of the University of Dundee.
Sir Pete will be joined by Sheila Voas, Chief Veterinary Officer for Scotland, former NFUS President Nigel Miller, SRUC Board member Jane Craigie, and Dr Kate Richards, who is a non-executive director on the SAC Commercial Board and currently the junior vice president of the RCVS, in line to become President in July.
Professor Caroline Argo, currently Dean of SRUC’s North Faculty, will lead the project for SRUC.
A report from BiGGAR Economics has found that the vet school could add £26 million GVA and 242 jobs to Scotland by 2030.
Professor Wayne Powell, Principal and Chief Executive of SRUC, said: “We are an ambitious institution with a bold vision for the future. This is a ground-breaking model to expand access to educational opportunities and broaden the range of potential students who would not ordinarily be able to attend a vet school. It will also help solve existing skills shortages across Scotland.
“We see a key role of the new vet school in sustaining primary agriculture and hence food and drink productivity, with the welfare of both livestock and companion animals at its heart. The school will produce champions for best-in-class animal welfare in support of these industries, which will help improve productivity, effectiveness, and sustainability.”
“Building on the excellent new facilities we have already announced for Aberdeen and Inverness, there is a lot of work still to be done, but we are ready to seize the opportunity.”
The association says that the day of lectures is mainly targeted at those who are starting on their path of ophthalmology, but old hands may also learn a few new tricks.
Topics will include how to get the most from the ophthalmic examination, diagnostics and what options there are for career growth in our specialty.
There will be live panel discussions to give attendees the opportunity to ask any questions they have.
Tickets costs £100+VAT for BrAVO members, £60+VAT for nurses and interns, and £40+VAT for students.
The deadline for registration is Tuesday 16th March at 5:00pm.
To book your ticket, visit: https://www.eventbee.com/v/bravo-spring-meeting-2021/event?eid=164693974#/tickets
The VetGDP, which replaced the Professional Development Phase (PDP), provides a period of structured support to aid the transition of newly-registered veterinary surgeons from veterinary studies to life in the workplace.
VetGDP is being rolled out during 2021 and this year’s veterinary graduates will need to enrol on it.
One of the main features of VetGDP is the requirement for a trained VetGDP Adviser to be available in the practice to provide their new graduate with one-to-one, meaningful support and guidance, to help develop their confidence and capabilities.
In order for veterinary surgeons to become VetGDP Advisers they must complete an online training package being developed by the RCVS and formally commit to supporting new graduates.
Practices that have trained VetGDP Advisers and make this commitment will receive the status of an RCVS-Approved Graduate Development Practice.
The original plan was that practices who wish to employ this year’s cohort of graduates should have obtained RCVS-Approved Graduate Development Practice status by June 2021.
This has now been amended in recognition of the additional pressures that veterinary practice teams are under as a result of the pandemic.
Practices who employ graduates this year will now have until December 2021 to achieve this status, provided they have started to work towards RCVS-Approved Graduate Development Practice status and commit to supporting their new graduate while they do so.
Dr Linda Prescott-Clements, RCVS Director of Education, said: “The ongoing pandemic restrictions, specifically changes made by the government to veterinary professionals’ key worker status on 13 January, means that there are now significant additional pressures on practice teams, particularly in terms of staffing, as many members of the profession will be balancing their work with caring responsibilities. We recognise this and, as such, we have updated the timeframe for the completion of our training for VetGDP Advisers.
“I would also like to personally thank the 850 vets who have already registered their interest in becoming VetGDP Advisers. It is very reassuring to see so many members of the profession committed to supporting new members of the profession, and wanting to engage with the training and with VetGDP to help nurture and develop our future vets through their first few years in practice.”
The College will be holding three VetGDP workshops in February. Each workshop will feature the same content, so there’s no need to attend more than one.
They take place on:
The workshops are open to anyone in the veterinary team including veterinary surgeons who may be considering becoming a VetGDP Adviser, practice managers and others involved in graduate recruitment and anyone else who would like to find out more about VetGDP.
The sessions will be interactive and there will be a significant portion of time given over to Q&As. The RCVS Chair of Education Committee, Dr Sue Paterson FRCVS, and Dr Linda Prescott-Clements, will be available to answer any questions which can be submitted live during the event. You can also submit questions as you register for the workshop at: www.rcvs.org.uk/vetgdpworkshops.
For more information, visit: www.rcvs.org.uk/vetgdp
The Working Group, which was formed in January, is chaired by Nigel Gibbens (pictured right) and composed of representatives from BVA specialist divisions and affiliate groups, and others with relevant expertise and knowledge.
As the Association says, the RCVS review will potentially have a far-reaching impact on the future of the veterinary profession, animal health and welfare, and the relationships vets have with their clients.
Of particular concern are the impact of remote prescribing on animal welfare and how limited-service providers (ie those offering online consultations only) will affect the commercial viability of full-service providers.
It is therefore hugely important that the BVA's response represents the opinions and evidence of as many people in the profession as possible.
Information about the BVA Working Group, including the minutes of meetings held so far and the 'themes' document which reflects the group's current thoughts, can be found here: https://www.bva.co.uk/about-us/our-structure/working-groups/
Nigel said: "I encourage you to look at this information carefully, and feed in any evidence that you wish the group to consider along with your thoughts on the content of the BVA response to the RCVS. You can do this via BVA’s Head of Policy & Governance Amelia Findon (ameliaf@bva.co.uk) who will ensure that comments are collated and considered by our group.
"The breadth of opinion across the profession means that the BVA response cannot please everyone, nor should it attempt to. However, it will be based on available evidence and a good understanding of the full scope of views. BVA policy will thus reflect the majority view whilst embracing the positive potential of technological innovations that will inevitably change the way we interact with clients. I urge you to take the time to consider the implications and let us have your thoughts."
The review, announced earlier this year, was recommended to RCVS Council by its Standards Committee following its exploration of the implications of new technologies for both animal health and welfare and veterinary regulation.
The main areas under consideration include the provision of 24-hour emergency cover and the interpretation and application of an animal being under the care of a veterinary surgeon.
The initial stages of this review had been drafted for Standards Committee to consider at its meeting on 9 September, where the outline timetable was also discussed.
Standards Committee Chair Melissa Donald, said: "This is set to become one of our most fundamental reviews of RCVS guidance in recent years.
"Considering the complexity of the issues in question, and their importance to animal owners and the professions alike, it is vital that we allow ourselves enough time to ensure this review is as thorough and comprehensive as possible.
"We have a clear responsibility to seek, understand and, where we can, accommodate the opinions and experiences of as many different people from within and around the professions and the public as possible. I would urge my fellow vets and vet nurses to please find some time to consider these issues very carefully over the coming weeks and months, and to send us their views."
The review will comprise several stages and is expected to take around 12 months to complete. The outline timetable, which may be subject to change, is as follows:
October 2019 – January 2020: six-week Call for Evidence, followed by independent qualitative analysis of all evidence received
February – March: Select Committee-style meetings and independent qualitative analysis of additional evidence gathered [NB this stage is subject to Standards Committee requirements, depending on the evidence gathered.]
April – June: Consider all evidence and draft any new policy
July – August: six-week public consultation on draft policy
September – October: independent review of consultation responses, and production of any proposals for change
November 2020: Finalise any proposals for change and publish any new guidance
To support and promote the various stages of the review the College is also planning a programme of stakeholder engagement, and will also provide regular updates on progress to both Council and the wider profession.
Members of the professions and the public will be able to follow the progress of the review via the RCVS website at: www.rcvs.org.uk/undercare
Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters associated with severe equine asthma, previously known as recurrent airway obstruction (RAO).
Equisolon Jar contains 180g of powder and comes with a measuring spoon.
One scoop is enough to treat 150kg bodyweight at a dose of 1mg/kg and therefore one jar can treat a 600kg horse for 10 days.
Equisolon was previously available as a box of 10 x 9g pre-measured sachets with one sachet sufficient to treat a 300kg horse and a box contained enough sachets to treat a 600g horse for five days.
Alana McGlade, national sales manager at Dechra said: “The addition of Equisolon Jar to the Equisolon range provides vets with the flexibility to choose between a jar featuring a convenient measuring spoon and a box of easy to dose pre-measured sachets
www.dechra.co.uk/products/horse/prescription
Bimeda has announced the launch of Butagran Equi (phenylbutazone), to join its range of analgesics and anti-inflammatories.
Bimeda says that Butagran Equi provides rapid onset of activity with the added convenience for horse owners or professionals of being presented as an easy-to-administer sweetened powder.
Indications include musculo-skeletal conditions that require relief from pain and a reduction in the associated inflammation, including lameness associated with osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation.
Head of Bimeda technical services Padraig Hyland MVB said: "Butagran Equi is particularly suited where continued mobility is considered desirable. It is also of value in limiting post-surgical inflammation, myositis and other soft tissue inflammation and can be used as an anti-pyretic where this is considered advisable, such as in viral respiratory infections. And being a sweetened powder it's quite straightforward for horse owners to administer and dose as prescribed."
He added: "Butagran Equi follows the launch of a number of new products and is proof our desire to provide a comprehensive and relevant equine portfolio backed up with first class technical support."
Merial is inviting all equine veterinary surgeons that are going to BEVA Congress this year to the launch of updated ProteqFlu, its equine flu vaccine which now includes protection against the latest Clade 2 strains, including Richmond 07.
Speakers at the event include specialist Dr Richard Newton (pictured right), Head of Epidemiology and Disease Surveillance at the Animal Health Trust (AHT), and Dr Romain Paillot Head of Immunology at the AHT. Dr Newton will explain why the inclusion of the Clade 2 strain is so important for horse health, and the equine industry as a whole.
Louise Radford MRCVS from Merial said: "We're all incredibly excited as the event will mark the launch of the UKs first and only fully updated equine flu vaccine that contains both a Clade 1 and Clade 2 antigen. The new ProteqFlu® vaccine fully represents the latest 2014 OIE recommended EIV strains."
The launch is being held at the Hotel Du Vin, Birmingham on Thursday 11 September 2014. Presentations will cover 'A virological and immunological perspective on Clade 2 & EIV', 'How technology makes the difference' and independent vaccine trial results.
The evening starts at 6.30pm and includes dinner and evening entertainment.
To book, contact, Jo Gater-Willats, or Merial Customer Support on 0800 6000123.
Petlog is announcing details of National Microchipping Month at BSAVA, which this year will include a special offer through which pet owners can update their registered details free of charge, and a 10% discount on SureFlap microchip cat flaps to all veterinary practices that agree to stock SureFlap and take part in the June initiative.
Celia Walsom, Petlog Executive said: "On top of the launch of National Microchipping Month 2011 we will be releasing details about the 'Petlog's Featured Practice' competition, our social media campaign enabling veterinary practices to send in images of themselves with their happy customers: selected images will be featured online and there will be a unique prize for the overall winners.
She added: "Visitors to the Petlog stand will also be able to pick up their own personal copy of the Kennel Club's Veterinary Practice Guide to Dog Health on a handy disk."
Meanwhile, you can see SureFlap on stand 203 at Congress or visit: www.sureflap.co.uk/trade.
The RCVS Disciplinary Committee has dismissed a case against a London-based veterinary surgeon, having found charges related to fraudulent registration not proved.
Miss Maria Becerra Parga was charged with fraudulently entering her name on the Register of Veterinary Surgeons, by submitting a registration application in 2005 that contained a forged certificate of good standing from the Distinguished Official Veterinary Association of Lugo, Spain.
The Committee said that, in order to conclude Miss Becerra Parga had acted dishonestly, it needed to be sure that when she submitted the certificate to the RCVS she knew it was not genuine.
Miss Becerra Parga admitted that she did not make any application for the certificate directly to the Lugo Association. She accepted that the certificate she supplied to the College (the number of which was genuine and corresponded to a male veterinary surgeon registered in Spain) was a forgery, and that it contained a reference to her degree, a statement of good conduct, and was dated before she had a need for it; however, she said, this had been given to her by a friend and veterinary colleague and she had understood that she had been given a temporary membership of the Lugo Association for the purpose of registering with the RCVS. She also said that she had left these arrangements to her colleague and assumed that the document she had been given was genuine.
Her colleague, called as a witness by the College, said that Miss Becerra Parga had admitted the fraud to her and she denied that she had given the certificate to Miss Becerra Parga. Her friend said that she gave no more than general guidance because she knew that Miss Becerra Parga would be guided by a UK company that would arrange for her registration with the RCVS and through which she would be employed. She thought it possible that she had told Ms Becerra Parga that she needed a letter of recommendation, but she was not sure.
After careful consideration, the Committee preferred the evidence of Miss Becerra Parga and found her account to be "consistent with her naivety, inexperience and trusting nature" and "was sure that she did not forge the document herself". It found that to the extent that Miss Becerra Parga read the certificate at all when given it, she obviously did not notice its date or significance. The Committee was not able to say who was responsible for forging the certificate.
The Committee also dismissed an argument RCVS Counsel put forward, that Miss Becerra Parga had neither offered nor made payment for the certificate, and that she had forged the certificate to avoid a payment. The Committee said it did not find it credible that a veterinary surgeon, in work with a supportive family, who obviously was easily able to obtain proof of her good character directly from the university if necessary, would have jeopardised her entire career by forging the document, let alone for a small financial advantage.
The Committee directed that the charges be dismissed.
Elanco Companion Animal Health has announced that its Duvaxyn IE and IE-T Plus vaccines have been licensed for active immunisation against OIE recommended clade 1 and clade 2 equine influenza strains, the first vaccines to be so licensed.
The company says the updated license is a result of a recent challenge study which demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to induce cross protection against clade 2 strain A/equi-2/Richmond/1/07 (H3N8) two weeks after two doses of the primary course1 were given. Cross-protection was further supported by another study2 measuring serum antibody response to the Richmond '07 strain 52 weeks after the three dose primary vaccination course.
The OIE (World Organisation for Animal Health) updated its equine influenza vaccine recommendations in 2010 to reflect the fact that all field strains characterised through 2008 and 2009 were of clade 1 or 2 of the Florida sub-lineage. The antigenic difference between viruses of these clades could potentially compromise the effectiveness of vaccines containing a representative of a single clade3.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health UK, said: "Whilst no vaccine has been updated to match the current OIE recommendations, the results of our challenge study and subsequent licence update provide reassurance that horses vaccinated with Duvaxyn will be protected against clinical signs of disease caused by currently circulating strains of equine influenza, including those the OIE has identified as being of concern.
"Further reassurance is also given with the confirmation in our study that Duvaxyn IE-T Plus elicits a cell mediated immune response, recognised to play an important role to aid in viral clearance and further enhances protection against strains circulating in the field." 4
The live virus challenge study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two doses of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Richmond/1/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Duvaxyn IE-T Plus is the only inactivated whole virus carbomer adjuvanted equine influenza vaccine in the UK. According to Elanco, experts in the field of human vaccination have expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins including the conserved nucleoprotein, which shows no antigenic drift, in the vaccine5.
References
The Smart Home Monitoring Kit for pets includes an indoor camera which comes with an in-built temperature sensor and night vision, a door sensor and a Smart Plug which can be remotely activated to turn on a radio, lamp, portable heater or fan to help keep animals content.
Although designed primarily for pet owners, Petplan says the kit is also being used by some veterinary practices to help provide additional security and monitoring capabilities within the practice.
The kit also contains an SD card allowing clients to share footage of their pet in the home with their veterinary surgeon when explaining behavioural symptoms. Likewise the practice will be able to record and share footage with their staff or clients.
Isabella Von Mesterhazy, Head of Marketing at Petplan, said: "For Petplan, keeping pets healthy always has been and always will be our priority. Spending time away from your pet can be hard, so the new pet Monitoring Kit addresses this problem by providing welcome peace of mind that they are safe and well. We are delighted to be able to offer Petplan veterinary practices and their staff the chance to get their hands on a Monitoring Kit at an exclusive price."
To find out more about the exclusive offer available for Petplan veterinary practices and staff until 9th December, visit petplanvet.co.uk.
Bimeda has announced the launch of Bilovet, a new tylosin-based antibiotic for cattle and pigs.Padraig Hyland, Head of Technical Veterinary Services at Bimeda said: ''It is with great pleasure that I announce the launch of our much anticipated Bilovet 200 mg/ml solution for injection for cattle and pigs as the latest addition to Bimeda's range of essential antibiotics.
Bilovet contains Tylosin 200 mg/ml and is the second Tylosin-based injectable antibiotic to be licensed for cattle - including dairy cattle - in the UK. Bilovet is licensed in cattle for the treatment of respiratory infections, metritis, mastitis, interdigital necrobacillosis and calf diphtheria as well as a range of pig infections, including enzootic pneumonia, haemorrhagic enteritis, erysipelas, arthritis and metritis".
Bimeda's Head of Bimeda R+D, Xavier Molins said: "Bilovet is a completely new development for a product that includes a new species (cattle). Bimeda have made a significant investment in bringing Bilovet to market, including conducting new Environmental Risk Assessment studies according to current guidelines and regulations.''
For more information, ring 01248 725 400 or email: uksales@bimeda.com
Defra's new measures include:
Eleven additional licences for badger control covering parts of Devon, Wiltshire, Somerset, Dorset and Cheshire. Licences have been granted for supplementary badger control in areas of Gloucestershire and Somerset which have completed their original four-year licences.
The relaunch of the Badger Edge Vaccination Scheme following suspension due to a global shortage of TB vaccine, with groups invited to submit expressions of interest and feedback on the criteria for the scheme.
A new bTB Advisory Service for farmers to provide advice on-farm and by phone or email to farmers in High Risk and Edge Areas on bTB biosecurity and risk-based trading, set to launch this autumn.
Tighter control of Inconclusive Reactors (IRs) in the High Risk and Edge Area, to come into force from 1 November.
British Veterinary Association (BVA) President Gudrun Ravetz said: "Today’s announcement sees 11 new licences issued and, while BVA supports badger culling as part of a comprehensive strategy for tackling bovine TB, we will continue to call on the Government to use the targeted and humane method of cage trapping and shooting only - rather than the current method of controlled shooting.
"As one of the many tools in the toolbox, we welcome the re-commencement of the Badger Edge Vaccination Scheme, particularly if used as a ‘firebreak’ to mitigate the spread of the disease into the low risk areas. The introduction of a TB Advisory Service will provide valuable additional support for farmers, who we’d encourage to continue working with local vets on biosecurity and herd health planning.
"Yet we are concerned that Government policy seems to have moved away from the original, evidence-based proposal of a six-week time limit for badger control within the open season, which enables an intensive, coordinated and effective operation in order to secure optimum disease control benefits.
"In terms of numbers, it is clear that badger population estimates have previously demonstrated considerable uncertainty and imprecision. It is critical that as accurate as possible population estimates, using an evidence-based methodology, are obtained and made openly available.
"We would urge clarity over cull timeframes, numbers and mid-cull review methodology to ensure that the progress made, enabling the application for Officially TB Free status, is not undermined."
Today’s Defra update follows a consultation on licensed badger control conducted at the start of 2017, to which the British Veterinary Association (BVA), British Veterinary Zoological Society (BVZS) and the Association of Government Veterinarians (AGV) submitted a formal, joint response.
Photo: Young Eurasian Badger (Meles Meles), by BadgerHero, CC BY-SA 3.0
The company says the return to a ‘new normal’ post-lockdown provides a significant opportunity for practices to apply a renewed focus to preventative healthcare, recommending parasiticides as a way to improve animal welfare and generate practice revenue, which is vital for economic recovery.
Caitrina Oakes, Vetoquinol Managing Director UK and Ireland, said: “With many pet owners spending more hours than ever with their pets during lockdown, companion animal parasiticides have never been more important – making Profender and Drontal highly relevant in the current environment.”
She added: “It’s a very challenging time for many veterinary practices as everyone adapts to the post-COVID world. I’m looking forward to seeing how the passion and ambition we bring to our brands helps Profender and Drontal to grow and helps us to better serve the needs of the veterinary community, both now and in the future.”
Up to date information on the brands and their distribution can be found on the Vetoquinol website, www.vetoquinol.co.uk, by calling 01280 814500, or practices can contact their Vetoquinol Territory Manager directly.
DG Sanco, the EU Directorate General for Health and Consumers, has launched a worldwide photo competition to mark World Vet Year: 'Vets in your daily life'
Entries need to be photos of a vet (or vets) at work or in any situation which shows the diverse nature of the job. Five winners will win 1000 Euros worth of photographic equipment. The overall winner will win an additional 2000 Euros worth of photographic equipment. All winners will also be given travel and accommodation for the awards ceremonies in Paris and Brussels.
Anyone (except for employees of the European Institutions, and their families) can enter the competition, which closes on 31st March 2011. More details can be found at: www.vetsinyourdailylife.org.
Here's the promotional video for the competition:
For those new to the club, the idea is that every two weeks, we pick an article in Veterinary Practice and invite the author to join us on VetSurgeon.org, so that you can ask questions and discuss the subject with one another.
As a bonus, you can claim time spent reading or participating in the discussion towards your annual CPD requirement (press the claim CPD button at the top right of the question thread).
To take part in this session, first read Ed's article here: https://www.veterinary-practice.com/article/endoscopic-retrieval-of-foreign-bodies.
Then come and post your questions or discussion points here: https://www.vetsurgeon.org/001/veterinary-clinical/small-animal/f/misc-clinical-discussions/30618/do-you-have-questions-about-endoscopic-retrieval-of-foreign-bodies-clinical-article-club
The company's charity of the year is chosen by employees at its annual conference in October. Fundraising then begins the following January.
This year, fundraising activities included cake sales, 'wearing blue days' and dog shows. Others took a more energetic approach: a team from Tone Veterinary Centre in Taunton cycled the equivalent of Land’s End to John O’Groats on exercise bikes over a fortnight, raising £525, while groomer Ceri James from Petherton Vets in Cardiff climbed Ben Nevis.
Simon Innes, CVS Chief Executive said: "Each year, thousands of cats, dogs, small animals and horses rely on the hospitals, clinics and rehoming services run by Blue Cross so it was a very natural charity for us to support and the overwhelming winner of last year’s vote.
"Yet again, our teams have surpassed themselves by really getting behind our fundraising efforts and showing great creativity and dedication to the task. Judging by some of the photos, they also seem to have had a great deal of fun. We held a group-wide charity day during July in which all parts of the business participated. It was a fantastic event and really showed the power of collective fundraising."
Matt Cull, Deputy Director of Fundraising at Blue Cross, said: "The dedication from CVS to fundraise for our pets through many different activities is so inspiring. We are very grateful to all the teams for helping Blue Cross as the money raised will assist us in helping thousands of pets in need and support our other charitable activities, such as our education programmes and bereavement support service. Pets change lives and with this generous help, we can change theirs."
Photo: Simon Innes CVS Group Chief Executive; Diane James, Blue Cross; Piers Gibbon, CVS Conference compere
The upgraded site uses 'machine learning', a type of artificial intelligence based on pattern recognition, to offer personalised content. The technology is now commonly used in consumer sites, such as Netflix and Amazon, but until now has not been used in the veterinary world. Content is further personalised for those vets and nurses that complete their profile on the site.
The upgrade was commissioned after Boehringer carried out a user experience survey of its old website, which revealed that whilst vets appreciated the CPD and educational materials, many were trawling through content that was not of interest to them or struggling to find what they wanted.
Jemima Mead, brand manager at Boehringer, said: "We aimed to create an engaging portal – a one-stop shop for vets who want to access high quality CPD and/or relevant information about any of our products. Vets are busy people so need to find relevant information quickly – giving them more time to focus on their clinical responsibilities. Our new slick site, tailored to their individual professional preferences, provides a valuable service that simply has not existed before."